Clinical Trial Update: Risk Evaluation and Education for Alzheimer's Disease [NA]

View source ↗

Summary

This clinical trial update from NHGRI reports the completion of a study on risk evaluation and education for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: National Human Genome Research Institute (NHGRI) | Conditions: Alzheimer's Disease | NA | Status: COMPLETED